Literature DB >> 8552866

Pulmonary aspergillosis: early diagnosis improves survival.

M von Eiff1, N Roos, R Schulten, M Hesse, M Zühlsdorf, J van de Loo.   

Abstract

Bronchoscopy obtaining bronchoalveolar lavage (BAL) fluid and bronchial secretions (BS) and/or high-resolution computed tomography (CT) of the lungs were performed in 33 patients with pulmonary aspergillosis from 1987 to 1992. The sensitivity of BAL fluid or BS for detecting histologically proven fungal disease was 33 and 50%, respectively, whereas positive serologies were only documented in 8% of the cases. CT scans contributed to the early diagnosis of opportunistic fungal pneumonia: characteristic CT signs were found in 16 of 19 episodes. The more frequent use of bronchoscopy and CT scans between 1990 and 1992 compared to 1987-1989 for the differential diagnosis of new pulmonary infiltrates resulted in earlier appropriate treatment. The average introduction of intravenous (i.v.) antifungal therapy after the onset of pneumonia was shifted from 12 to 7 days (p < 0.05). The timely implementation of i.v. antimycotic therapy had a significant impact on survival. Initiation of antifungal treatment later than 10 days after the onset of pneumonia resulted in a mortality of 90%, as opposed to 41% with an earlier start of antimycotics (p < 0.01). The earlier use of appropriate antifungal therapy in the second treatment period improved survival from 33 to 50% (NS). Bronchoscopy and high-resolution CT scans are mutually complementary diagnostic tools and should be performed as early as possible in the course of pneumonia for patients at high risk for aspergillosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8552866     DOI: 10.1159/000196477

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  74 in total

1.  Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.

Authors:  A Rañó; C Agustí; P Jimenez; J Angrill; N Benito; C Danés; J González; M Rovira; T Pumarola; A Moreno; A Torres
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

Review 2.  Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections.

Authors:  Themistoklis K Kourkoumpetis; Beth Burgwyn Fuchs; Jeffrey J Coleman; Athanasios Desalermos; Eleftherios Mylonakis
Journal:  Clin Infect Dis       Date:  2012-02-23       Impact factor: 9.079

3.  Diagnostic value of routine chest radiography in febrile, neutropenic children for early detection of pneumonia and mould infections.

Authors:  Stefan D Roberts; Gregory M Wells; Nilay M Gandhi; Nowell R York; Gabriela Maron; Bassem Razzouk; Randall T Hayden; Sue C Kaste; Jerry L Shenep
Journal:  Support Care Cancer       Date:  2012-01-26       Impact factor: 3.603

4.  Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity.

Authors:  Wei Hao; Yu-Xian Pan; Yan-Qing Ding; Sha Xiao; Kai Yin; Ya-Di Wang; Li-Wen Qiu; Qing-Lin Zhang; Patrick C Y Woo; Susanna K P Lau; Kwok-Yung Yuen; Xiao-Yan Che
Journal:  Clin Vaccine Immunol       Date:  2007-11-21

5.  Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

Authors:  Oliver A Cornely; Angelika Böhme; Dieter Buchheidt; Hermann Einsele; Werner J Heinz; Meinolf Karthaus; Stefan W Krause; William Krüger; Georg Maschmeyer; Olaf Penack; Jörg Ritter; Markus Ruhnke; Michael Sandherr; Michal Sieniawski; Jörg-Janne Vehreschild; Hans-Heinrich Wolf; Andrew J Ullmann
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

6.  Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.

Authors:  Greet De Vlieger; Katrien Lagrou; Johan Maertens; Eric Verbeken; Wouter Meersseman; Eric Van Wijngaerden
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

7.  β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Antonia Koltze; Peter Rath; Stefan Schöning; Jörg Steinmann; Thomas A Wichelhaus; Peter Bader; Konrad Bochennek; Thomas Lehrnbecher
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

8.  Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Santiago Grau; Rafael Cámara; Manuel Jurado; Jaime Sanz; Belén Aragón; Irmina Gozalbo
Journal:  Eur J Health Econ       Date:  2017-05-31

9.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.

Authors:  Shun-Ichi Kimura; Jun Odawara; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Kosei Matsue
Journal:  Int J Hematol       Date:  2009-10-20       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.